Your browser doesn't support javascript.
loading
The Impact of Excluding Nonrandomized Studies From Systematic Reviews in Rare Diseases: "The Example of Meta-Analyses Evaluating the Efficacy and Safety of Enzyme Replacement Therapy in Patients With Mucopolysaccharidosis".
Sampayo-Cordero, Miguel; Miguel-Huguet, Bernat; Malfettone, Andrea; Pérez-García, José Manuel; Llombart-Cussac, Antonio; Cortés, Javier; Pardo, Almudena; Pérez-López, Jordi.
Afiliação
  • Sampayo-Cordero M; Medica Scientia Innovation Research (MedSIR), Barcelona, Spain.
  • Miguel-Huguet B; Colorectal Unit, Department of Surgery, Hospital de Bellvitge, Barcelona, Spain.
  • Malfettone A; Medica Scientia Innovation Research (MedSIR), Barcelona, Spain.
  • Pérez-García JM; Medica Scientia Innovation Research (MedSIR), Barcelona, Spain.
  • Llombart-Cussac A; IOB Institute of Oncology, Quiron Salud Group, Madrid, Spain.
  • Cortés J; Medica Scientia Innovation Research (MedSIR), Barcelona, Spain.
  • Pardo A; Hospital Arnau de Vilanova, Universidad Católica de Valencia San Vicente Mártir, Valencia, Spain.
  • Pérez-López J; Medica Scientia Innovation Research (MedSIR), Barcelona, Spain.
Front Mol Biosci ; 8: 690615, 2021.
Article em En | MEDLINE | ID: mdl-34239895
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Guideline Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Guideline Idioma: En Ano de publicação: 2021 Tipo de documento: Article